Agf Investments LLC Bluebird Bio, Inc. Transaction History

Agf Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$8.96 - $16.31 $309,370 - $563,151	-34,528 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$11.24 - $21.0 $388,094 - $725,088	34,528 New	34,528 $660,000
Q4 2018 Feb 08, 2019	SELL	$59.1 - $93.26 $9,160 - $14,455	-155 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$88.86 - $117.49 $31,545 - $41,708	-355 Reduced 69.61%	155 $22,000
Q3 2018 Nov 07, 2018	BUY	$88.86 - $117.49 $25,413 - $33,602	286 Added 127.68%	510 $28,000
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $22,319 - $28,580	224 New	224 $35,000
Q1 2018 May 04, 2018	SELL	$105.8 - $150.94 $11,849 - $16,905	-112 Closed	0 $0
Q4 2017 Feb 07, 2018	BUY	$81.25 - $130.7 $2,600 - $4,182	32 Added 40.0%	112 $20,000
Q3 2017 Nov 09, 2017	BUY	$57.74 - $91.42 $4,619 - $7,313	80	80 $10,000

142

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.